§ 13F · FUND PROFILE
TAKEDA PHARMACEUTICAL CO LTD.
AUM · $20M (13F)Positions · 12Turnover · n/a · Q2Filed · Aug 8, 2025
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2025
FILED AUG 8, 2025
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | — | HilleVax, Inc. | 6.72M | $13M | 68.4% | ±0% |
| 2 | OVID | Ovid Therapeutics, Inc. | 5.75M | $2M | 9.7% | ±0% |
| 3 | XLO | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | 1.48M | $1M | 5.1% | ±0% |
| 4 | AMWL | American Well Corporation | 78K | $691K | 3.5% | ±0% |
| 5 | OVID | Ovid Therapeutics, Inc. | 1.78M | $588K | 3.0% | — |
| 6 | EQ | Equillium, Inc. | 1.82M | $575K | 2.9% | ±0% |
| 7 | STTK | Shattuck Labs, Inc. | 516K | $408K | 2.1% | ±0% |
| 8 | LYEL | Lyell Immunopharma, Inc. | 41K | $364K | 1.9% | −95% |
| 9 | — | Turnstone Biologics | 896K | $322K | 1.6% | ±0% |
| 10 | — | Third Harmonic Bio, Inc. | 37K | $200K | 1.0% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE TAKEDA SIGNAL
AC read
TAKEDA PHARMACEUTICAL CO LTD is a Other fund managing $20 million in assets. The fund runs a focused portfolio of just 12 positions.
Read the full dossier →